Clinical Trial Update: Single High-dose of Liposomal Amphotericin B in Combination With B/F/TAF for HIV/AIDS-associated Talaromycosis [NA]

View source ↗

Summary

This clinical trial update describes a study evaluating a single high-dose liposomal amphotericin B combined with B/F/TAF for HIV/AIDS-associated talaromycosis.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids-associated Talaromycosis

Drugs mentioned

• AMBISOME (AMPHOTERICIN B)
• BIKTARVY (BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE)

Snippet

Sponsor: Shanghai Public Health Clinical Center | Conditions: HIV/AIDS-associated Talaromycosis | NA | Status: NOT_YET_RECRUITING